Canada Life’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $86.1M | Buy |
192,144
+4,540
| +2% | +$2.12M | 0.15% | 121 |
|
|
2025
Q4 | $85.1M | Sell |
187,604
-86,532
| -32% | -$37.3M | 0.15% | 122 |
|
|
2025
Q3 | $108M | Buy |
274,136
+3,424
| +1% | +$1.43M | 0.16% | 119 |
|
|
2025
Q2 | $121M | Sell |
270,712
-12
| -0% | -$5.53K | 0.19% | 104 |
|
|
2025
Q1 | $131M | Buy |
270,724
+846
| +0.3% | +$394K | 0.23% | 84 |
|
|
2024
Q4 | $109M | Sell |
269,878
-48,403
| -15% | -$22.4M | 0.19% | 97 |
|
|
2024
Q3 | $148M | Sell |
318,281
-2,003
| -0.6% | -$962K | 0.26% | 73 |
|
|
2024
Q2 | $150M | Buy |
320,284
+50,062
| +19% | +$21.7M | 0.28% | 62 |
|
|
2024
Q1 | $113M | Sell |
270,222
-8,327
| -3% | -$3.52M | 0.23% | 87 |
|
|
2023
Q4 | $113M | Sell |
278,549
-5,077
| -2% | -$1.88M | 0.25% | 79 |
|
|
2023
Q3 | $98.6M | Buy |
283,626
+2,798
| +1% | +$979K | 0.24% | 84 |
|
|
2023
Q2 | $99.3M | Buy |
280,828
+7,171
| +3% | +$2.42M | 0.24% | 84 |
|
|
2023
Q1 | $86.3M | Sell |
273,657
-4,667
| -2% | -$1.4M | 0.21% | 93 |
|
|
2022
Q4 | $80.7M | Sell |
278,324
-19,914
| -7% | -$6.07M | 0.21% | 101 |
|
|
2022
Q3 | $86.2M | Sell |
298,238
-1,219
| -0.4% | -$351K | 0.25% | 81 |
|
|
2022
Q2 | $84.5M | Sell |
299,457
-100,839
| -25% | -$27M | 0.22% | 92 |
|
|
2022
Q1 | $110M | Sell |
400,296
-5,326
| -1% | -$1.26M | 0.23% | 82 |
|
|
2021
Q4 | $88.8M | Buy |
405,622
+16,035
| +4% | +$3.12M | 0.18% | 107 |
|
|
2021
Q3 | $71.1M | Buy |
389,587
+1,011
| +0.3% | +$197K | 0.17% | 119 |
|
|
2021
Q2 | $78.3M | Buy |
388,576
+103,524
| +36% | +$21.7M | 0.18% | 117 |
|
|
2021
Q1 | $60.9M | Sell |
285,052
-53,337
| -16% | -$11.7M | 0.15% | 155 |
|
|
2020
Q4 | $79.8M | Buy |
338,389
+23,385
| +7% | +$5.37M | 0.15% | 150 |
|
|
2020
Q3 | $85.7M | Buy |
315,004
+25,535
| +9% | +$7.04M | 0.19% | 124 |
|
|
2020
Q2 | $83.7M | Buy |
289,469
+25,745
| +10% | +$6.98M | 0.19% | 121 |
|
|
2020
Q1 | $63.1M | Sell |
263,724
-8,772
| -3% | -$2.01M | 0.17% | 134 |
|
|
2019
Q4 | $59.2M | Buy |
272,496
+47,230
| +21% | +$9.56M | 0.13% | 175 |
|
|
2019
Q3 | $38.2M | Sell |
225,266
-3,375
| -1% | -$597K | 0.09% | 239 |
|
|
2019
Q2 | $41.9M | Buy |
228,641
+10,286
| +5% | +$1.8M | 0.1% | 228 |
|
|
2019
Q1 | $40.1M | Buy |
218,355
+27,628
| +14% | +$5.1M | 0.11% | 205 |
|
|
2018
Q4 | $30.4M | Sell |
190,727
-2,035
| -1% | -$353K | 0.09% | 230 |
|
|
2018
Q3 | $37.2M | Sell |
192,762
-23,318
| -11% | -$4.15M | 0.09% | 229 |
|
|
2018
Q2 | $36.8M | Buy |
216,080
+2,043
| +1% | +$317K | 0.09% | 239 |
|
|
2018
Q1 | $34.9M | Sell |
214,037
-6,948
| -3% | -$1.13M | 0.08% | 243 |
|
|
2017
Q4 | $33.1M | Buy |
220,985
+1,555
| +0.7% | +$230K | 0.08% | 258 |
|
|
2017
Q3 | $32.9M | Sell |
219,430
-10,263
| -4% | -$1.54M | 0.08% | 251 |
|
|
2017
Q2 | $29.6M | Buy |
229,693
+54,178
| +31% | +$6.52M | 0.08% | 264 |
|
|
2017
Q1 | $19.2M | Buy |
175,515
+1,282
| +0.7% | +$113K | 0.05% | 346 |
|
|
2016
Q4 | $12.9M | Sell |
174,233
-2,074
| -1% | -$169K | 0.04% | 422 |
|
|
2016
Q3 | $15.4M | Buy |
176,307
+5,142
| +3% | +$486K | 0.04% | 375 |
|
|
2016
Q2 | $14.7M | Buy |
171,165
+40,867
| +31% | +$3.53M | 0.04% | 379 |
|
|
2016
Q1 | $10.3M | Buy |
130,298
+5,552
| +4% | +$502K | 0.04% | 397 |
|
|
2015
Q4 | $15.7M | Sell |
124,746
-280
| -0.2% | -$33.8K | 0.06% | 302 |
|
|
2015
Q3 | $13M | Buy |
125,026
+4,595
| +4% | +$590K | 0.05% | 328 |
|
|
2015
Q2 | $14.8M | Sell |
120,431
-5,869
| -5% | -$740K | 0.05% | 345 |
|
|
2015
Q1 | $14.9M | Sell |
126,300
-2,971
| -2% | -$356K | 0.05% | 354 |
|
|
2014
Q4 | $15.3M | Sell |
129,271
-18,860
| -13% | -$2.12M | 0.05% | 351 |
|
|
2014
Q3 | $16.7M | Buy |
148,131
+20,548
| +16% | +$1.96M | 0.06% | 334 |
|
|
2014
Q2 | $12M | Buy |
127,583
+16,250
| +15% | +$1.14M | 0.04% | 387 |
|
|
2014
Q1 | $7.83M | Buy |
111,333
+2,438
| +2% | +$193K | 0.03% | 470 |
|
|
2013
Q4 | $8.13M | Sell |
108,895
-13,215
| -11% | -$920K | 0.03% | 462 |
|
|
2013
Q3 | $9.24M | Buy |
122,110
+93,210
| +323% | +$7.42M | 0.04% | 413 |
|
|
2013
Q2 | $2.31M | Buy |
+28,900
| New | +$2.13M | 0.02% | 389 |
|
Other funds holding VRTX
VCM
VPM
Canada Life's VRTX Position: Q1 2026 in Review
Canada Life increased its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q1 2026, buying an estimated $2.12M and bringing the position to 192,144 shares worth $86.1M. The position accounts for 0.15% of the portfolio, ranked #121.
Canada Life first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $150M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Canada Life held 192,144 shares of Vertex Pharmaceuticals worth $86.1M as of Q1 2026.
- Canada Life bought 4,540 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.12M.
- Vertex Pharmaceuticals made up 0.15% of Canada Life's portfolio in Q1 2026, its #121 holding.
- Canada Life first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Canada Life's Vertex Pharmaceuticals position peaked at $150M in Q2 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.